Financial Council’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Sell
1,247
-15
-1% -$15.3K 0.49% 32
2026
Q1
$1.16M Hold
1,262
0.45% 34
2025
Q4
$1.36M Buy
1,262
+6
+0.5% +$5.74K 0.54% 32
2025
Q3
$958K Buy
1,256
+9
+0.7% +$6.7K 0.43% 35
2025
Q2
$972K Hold
1,247
0.47% 35
2025
Q1
$1.03M Hold
1,247
0.56% 32
2024
Q4
$963K Hold
1,247
0.5% 34
2024
Q3
$1.1M Hold
1,247
0.58% 31
2024
Q2
$1.13M Buy
1,247
+24
+2% +$19.2K 0.63% 29
2024
Q1
$951K Hold
1,223
0.56% 31
2023
Q4
$713K Buy
1,223
+565
+86% +$330K 0.48% 34
2023
Q3
$353K Hold
658
0.28% 41
2023
Q2
$309K Buy
658
+42
+7% +$17.6K 0.24% 49
2023
Q1
$212K Hold
616
0.17% 66
2022
Q4
$225K Buy
+616
New +$218K 0.14% 60

Other funds holding LLY

Financial Council's LLY Position: Q2 2026 in Review

Financial Council reduced its Eli Lilly (LLY) stake by 1.2% in Q2 2026, selling an estimated $15.3K and leaving 1,247 shares worth $1.5M. The position accounts for 0.49% of the portfolio, ranked #32.

Financial Council first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Financial Council held 1,247 shares of Eli Lilly worth $1.5M as of Q2 2026.
  • Financial Council sold 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
  • Eli Lilly made up 0.49% of Financial Council's portfolio in Q2 2026, its #32 holding.
  • Financial Council first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Financial Council's 13F filing for Q2 2026, filed 4 Aug 2026.